Obermatt
See Similar Stocks →

Pulse Biosciences

NAQ:PLSE · US74587B1017
Health Care Equipment & SuppliesSmall

360

45
Medium confidence — indicative
Profit price85
Owner Earnings Yield1
Dividend Yield1
Price/Sales3
Price/Book95
Return on Capital1
Cash Return on Capital1
Return on Equity5
Profit margins4
Accruals91
Owner Earnings Margin1
Sales growth100
Profit growth27
Reinvestment42
Price momentum62
Debt load67
Refinancing39
Debt Payback1
Liquidity81
Analyst ratings100
Opinion Changes50
Price Target Upside22
Market mood71
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Pulse Biosciences doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Based on 4/5 components.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2014
Employees116
Websitepulsebiosciences.com
ISINUS74587B1017
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
CardiovascularDermatologyBiomedical EngineeringSurgeryOncologyHealth CareMedicalMedical DeviceTherapeutics

Description

Pulse Biosciences, Inc. (Pulse Biosciences) operates as a novel ablation company committed to health innovation using its patented Nano-pulse Stimulation (NPS) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of el…

Analysis

Weak and unloved

Pulse Biosciences, Inc. is weak and unloved: below-average business metrics and a price that reflects that disappointment.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is sturdy. The company scores 2/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
94
2026

All-time high

94

Jun 2026

All-time low

84

Mar 2026

Average rank

89

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
3
—
—
—
Price/Earnings
92
—
—
—
Price/Book
95
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
69
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Pulse Biosciences with its peers
KORU Medical Systems
NAQ:KRMD
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Everspin Technologies
NMQ:MRAM
42
CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →
Caris Life Sciences
NSQ:CAI
93
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
LENSAR
NAQ:LNSR
88
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Myriad Genetics
NSQ:MYGN
12
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Kimberly-Clark
NSQ:KMB
32
CountryUSA
IndustryHousehold Products
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →